US Stock MarketDetailed Quotes
SILK Silk Road Medical
- 26.950
- -0.090-0.33%
Close Jul 1 16:00 ET
- 26.950
- 0.0000.00%
Post 16:01 ET
1.07BMarket Cap-19671P/E (TTM)
27.100High26.890Low1.65MVolume26.950Open27.040Pre Close44.62MTurnover4.26%Turnover RatioLossP/E (Static)39.72MShares33.12552wk High7.27P/B1.04BFloat Cap6.08052wk Low--Dividend TTM38.76MShs Float75.800Historical High--Div YieldTTM0.78%Amplitude6.080Historical Low27.005Avg Price1Lot Size
Silk Road Medical Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -26.14%-15.32M | 1.74%-32.01M | -210.32%-8.45M | -43.84%-6.8M | 55.64%-4.62M | 17.51%-12.15M | 16.32%-32.58M | 76.17%-2.72M | 27.24%-4.73M | -15.16%-10.41M |
| Net income from continuing operations | 14.12%-14.14M | -1.33%-55.74M | -3.15%-13.01M | -23.93%-12.79M | 12.43%-13.48M | 1.31%-16.46M | -10.44%-55.01M | 14.15%-12.61M | 25.68%-10.32M | -46.10%-15.4M |
| Operating gains losses | ---- | -62.35%160K | 220.00%16K | --0 | --0 | 20.00%144K | 4,622.22%425K | --5K | --0 | --300K |
| Depreciation and amortization | -5.61%925K | 19.70%3.79M | -0.64%931K | 13.78%925K | 26.46%956K | 48.04%980K | 65.09%3.17M | 64.67%937K | 64.24%813K | 65.07%756K |
| Other non cash items | 2.18%281K | -16.25%1.05M | 2.21%278K | -37.80%260K | -54.75%238K | 605.13%275K | 694.30%1.26M | 276.62%272K | 74.90%418K | 1,543.75%526K |
| Change In working capital | -176.00%-11.57M | -130.88%-13.91M | -336.73%-5.23M | -108.01%-3.56M | 65.53%-929K | -9.40%-4.19M | 7.03%-6.03M | 270.08%2.21M | -159.00%-1.71M | -2.74%-2.7M |
| -Change in receivables | -84.45%-3.63M | 9.11%-5.61M | -81.58%-1.79M | 77.50%-279K | 17.68%-1.57M | 3.43%-1.97M | -122.90%-6.17M | -14.48%-988K | -260.83%-1.24M | -197.35%-1.91M |
| -Change in inventory | -137.22%-785K | -645.06%-10.78M | -899.30%-7.99M | -12.07%-3.01M | -1,905.71%-1.9M | 1,473.88%2.11M | 73.99%-1.45M | 154.92%999K | 18.34%-2.69M | -92.13%105K |
| -Change in prepaid assets | 2,010.48%2.37M | -278.67%-1.99M | -369.36%-1.64M | 141.82%266K | 76.30%-495K | -114.64%-124K | 31.99%-525K | -51.13%607K | -90.93%110K | 45.17%-2.09M |
| -Change in payables and accrued expense | -147.12%-9.19M | 108.71%5.92M | 226.44%6.25M | -103.61%-89K | 116.70%3.48M | -18.13%-3.72M | -13.01%2.84M | 44.34%1.91M | -24.11%2.47M | 80.34%1.61M |
| -Change in other current assets | 776.47%115K | -774.07%-236K | -32.00%17K | -760.00%-129K | -234.38%-107K | -240.00%-17K | 76.92%-27K | 350.00%25K | 54.55%-15K | 52.94%-32K |
| -Change in other current liabilities | 5.94%-443K | -76.09%-1.22M | 75.43%-85K | 7.80%-319K | 10.05%-340K | -223.95%-471K | -32.69%-690K | 70.58%-346K | -134.98%-346K | -15.24%-378K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -26.14%-15.32M | 1.74%-32.01M | -210.32%-8.45M | -43.84%-6.8M | 55.64%-4.62M | 17.51%-12.15M | 16.32%-32.58M | 76.17%-2.72M | 27.24%-4.73M | -15.16%-10.41M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 190.55%17.74M | 95.57%-7.18M | 98.49%-1.58M | 122.67%7.46M | 13.51%-19.16M | 394.69%6.11M | -323.10%-162.07M | -836.50%-104.95M | -512.84%-32.9M | -256.06%-22.15M |
| Net PPE purchase and sale | -35.19%-388K | 69.89%-1.51M | 71.09%-453K | 14.40%-333K | 55.58%-434K | 86.15%-287K | -5.24%-5.01M | 43.02%-1.57M | 65.64%-389K | -21.07%-977K |
| Net investment purchase and sale | 183.58%18.13M | 96.39%-5.67M | 98.91%-1.13M | 123.96%7.79M | 11.57%-18.72M | --6.39M | -302.92%-157.06M | -708.14%-103.38M | -457.21%-32.51M | -241.15%-21.17M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 190.55%17.74M | 95.57%-7.18M | 98.49%-1.58M | 122.67%7.46M | 13.51%-19.16M | 394.69%6.11M | -323.10%-162.07M | -836.50%-104.95M | -512.84%-32.9M | -256.06%-22.15M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | -97.22%3.89M | -99.06%1.06M | -89.28%130K | -94.01%1.59M | 560.71%1.11M | 1,901.99%139.7M | 6,208.70%111.73M | -45.90%1.21M | 1,156.07%26.59M |
| Net issuance payments of debt | ---- | --0 | --0 | --0 | ---- | ---- | --24.91M | ---1.09M | --0 | ---- |
| Net common stock issuance | --0 | -96.61%3.89M | -99.06%1.06M | -90.28%130K | 1.99%1.59M | 560.71%1.11M | 1,552.58%114.79M | 6,324.44%111.72M | -40.32%1.34M | -26.26%1.56M |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---125K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | -97.22%3.89M | -99.06%1.06M | -89.28%130K | -94.01%1.59M | 560.71%1.11M | 1,901.99%139.7M | 6,208.70%111.73M | -45.90%1.21M | 1,156.07%26.59M |
| Net cash flow | ||||||||||
| Beginning cash position | -63.59%20.21M | -49.75%55.51M | -43.28%29.19M | -67.68%28.4M | -46.09%50.58M | -49.75%55.51M | 58.31%110.46M | -51.39%51.46M | -13.99%87.87M | -1.11%93.83M |
| Current changes in cash | 149.06%2.42M | 35.75%-35.3M | -321.57%-8.98M | 102.16%788K | -271.87%-22.18M | 70.35%-4.93M | -235.06%-54.95M | -11.70%4.05M | -1,080.03%-36.41M | -182.00%-5.97M |
| End cash Position | -55.26%22.63M | -63.59%20.21M | -63.59%20.21M | -43.28%29.19M | -67.68%28.4M | -46.09%50.58M | -49.75%55.51M | -49.75%55.51M | -51.39%51.46M | -13.99%87.87M |
| Free cash flow | -26.35%-15.71M | 10.82%-33.52M | -107.55%-8.91M | -39.41%-7.13M | 55.64%-5.05M | 25.97%-12.43M | 13.98%-37.59M | 69.75%-4.29M | 32.94%-5.12M | -15.65%-11.38M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg